NIVF Valuation
NewGenIvf Group Ltd
$
1.980
- Overview
- Forecast
- Valuation
- Earnings
NIVF Relative Valuation
NIVF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NIVF is overvalued; if below, it's undervalued.
Historical Valuation
NewGenIvf Group Ltd (NIVF) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of NewGenIvf Group Ltd (NIVF) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：1.88
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
NewGenIvf Group Ltd. (NIVF) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
NewGenIvf Group Ltd. (NIVF) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
NewGenIvf Group Ltd. (NIVF) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
NewGenIvf Group Ltd. (NIVF) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
NewGenIvf Group Ltd. (NIVF) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
NewGenIvf Group Ltd (NIVF) has a current Price-to-Book (P/B) ratio of -0.04. Compared to its 3-year average P/B ratio of 3.13 , the current P/B ratio is approximately -101.30% higher. Relative to its 5-year average P/B ratio of 2.78, the current P/B ratio is about -101.47% higher. NewGenIvf Group Ltd (NIVF) has a Forward Free Cash Flow (FCF) yield of approximately -511.50%. Compared to its 3-year average FCF yield of -116.63%, the current FCF yield is approximately 338.55% lower. Relative to its 5-year average FCF yield of -103.45% , the current FCF yield is about 394.46% lower.
-0.04
P/B
Median3y
3.13
Median5y
2.78
-511.50
FCF Yield
Median3y
-116.63
Median5y
-103.45
Competitors Valuation Multiple
The average P/S ratio for NIVF's competitors is 0.54, providing a benchmark for relative valuation. NewGenIvf Group Ltd Corp (NIVF) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -16.18%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NIVF decreased by 99.72% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from 0.00 to 0.00.
The secondary factor is the Revenue Growth, contributed -16.18%to the performance.
Overall, the performance of NIVF in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is NewGenIvf Group Ltd (NIVF) currently overvalued or undervalued?
NewGenIvf Group Ltd (NIVF) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of NewGenIvf Group Ltd (NIVF) is between to according to relative valuation methord.
What is NewGenIvf Group Ltd (NIVF) fair value?
How does NIVF's valuation metrics compare to the industry average?
What is the current P/B ratio for NewGenIvf Group Ltd (NIVF) as of Sep 23 2025?
What is the current FCF Yield for NewGenIvf Group Ltd (NIVF) as of Sep 23 2025?
What is the current Forward P/E ratio for NewGenIvf Group Ltd (NIVF) as of Sep 23 2025?